A new urine test for prostate cancer shows significantly higher accuracy than current blood tests, achieving an AUC score of 0.92 compared to PSA tests' 0.65-0.75. This breakthrough, detailed in Cancer Research, could lead to routine screenings for the disease, potentially saving thousands of lives annually in the UK. A large-scale clinical trial involving 250,000-300,000 men is planned over the next eight years to validate the test's effectiveness in real-world settings. Experts are calling it a potential 'game changer' for prostate cancer diagnosis and treatment.

Prepared by Olivia Bennett and reviewed by editorial team.